Concepts (42)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Programmed Cell Death 1 Receptor | 2 | 2021 | 87 | 0.370 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2021 | 446 | 0.360 |
Why?
|
| Mouth Neoplasms | 2 | 2021 | 206 | 0.330 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2021 | 629 | 0.270 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2022 | 46 | 0.200 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2021 | 6 | 0.200 |
Why?
|
| Autistic Disorder | 1 | 2022 | 77 | 0.190 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 91 | 0.190 |
Why?
|
| Autism Spectrum Disorder | 1 | 2022 | 111 | 0.180 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 332 | 0.160 |
Why?
|
| Melanoma | 1 | 2021 | 335 | 0.150 |
Why?
|
| Neoadjuvant Therapy | 2 | 2021 | 104 | 0.100 |
Why?
|
| Antineoplastic Agents, Immunological | 2 | 2021 | 66 | 0.090 |
Why?
|
| Survival Analysis | 2 | 2021 | 714 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 756 | 0.070 |
Why?
|
| Mice | 3 | 2022 | 8474 | 0.070 |
Why?
|
| MEF2 Transcription Factors | 1 | 2022 | 36 | 0.050 |
Why?
|
| Cochlear Nerve | 1 | 2022 | 83 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2021 | 29 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 51 | 0.050 |
Why?
|
| Janus Kinase 2 | 1 | 2021 | 40 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 213 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2021 | 108 | 0.050 |
Why?
|
| Th17 Cells | 1 | 2021 | 116 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2021 | 228 | 0.050 |
Why?
|
| Animals | 3 | 2022 | 20881 | 0.050 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2021 | 132 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 266 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 199 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2021 | 7029 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 498 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 800 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2022 | 1851 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2022 | 902 | 0.040 |
Why?
|
| Mutation | 1 | 2021 | 1213 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 2358 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 2550 | 0.030 |
Why?
|
| Humans | 4 | 2022 | 68618 | 0.030 |
Why?
|
| Male | 2 | 2022 | 37321 | 0.020 |
Why?
|
| Female | 2 | 2022 | 38074 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 14862 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 21147 | 0.010 |
Why?
|